These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37723252)

  • 1. Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit.
    Miles-Jay A; Snitkin ES; Lin MY; Shimasaki T; Schoeny M; Fukuda C; Dangana T; Moore N; Sansom SE; Yelin RD; Bell P; Rao K; Keidan M; Standke A; Bassis C; Hayden MK; Young VB
    Nat Med; 2023 Oct; 29(10):2526-2534. PubMed ID: 37723252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Determination of Relative Risks for Clostridioides difficile Infection From Asymptomatic Carriage in Intensive Care Unit Patients.
    Worley J; Delaney ML; Cummins CK; DuBois A; Klompas M; Bry L
    Clin Infect Dis; 2021 Oct; 73(7):e1727-e1736. PubMed ID: 32676661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic surveillance of
    Newcomer EP; Fishbein SRS; Zhang K; Hink T; Reske KA; Cass C; Iqbal ZH; Struttmann EL; Burnham C-AD; Dubberke ER; Dantas G
    mBio; 2024 Mar; 15(3):e0330023. PubMed ID: 38329369
    [No Abstract]   [Full Text] [Related]  

  • 5. A multisite genomic epidemiology study of
    Miles-Jay A; Young VB; Pamer EG; Savidge TC; Kamboj M; Garey KW; Snitkin ES
    Microb Genom; 2021 Jun; 7(6):. PubMed ID: 34180789
    [No Abstract]   [Full Text] [Related]  

  • 6. A local-scale One Health genomic surveillance of
    Williamson CHD; Roe CC; Terriquez J; Hornstra H; Lucero S; Nunnally AE; Vazquez AJ; Vinocur J; Plude C; Nienstadt L; Stone NE; Celona KR; Wagner DM; Keim P; Sahl JW
    Microb Genom; 2023 Jun; 9(6):. PubMed ID: 37347682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-day prevalence of asymptomatic carriage of toxigenic and non-toxigenic Clostridioides difficile in 10 French hospitals.
    Le Monnier A; Candela T; Mizrahi A; Bille E; Bourgeois-Nicolaos N; Cattoir V; Farfour E; Grall I; Lecointe D; Limelette A; Marcade G; Poilane I; Poupy P; Kansau I; Zahar JR; Pilmis B;
    J Hosp Infect; 2022 Nov; 129():65-74. PubMed ID: 35640734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Analysis of Clostridioides difficile in 2 Regions of the United States Reveals a Diversity of Strains and Limited Transmission.
    Pecora N; Holzbauer S; Wang X; Gu Y; Taffner S; Hatwar T; Hardy D; Dziejman M; D'Heilly P; Pung K; Guh A; Qiu X; Gill S; Dumyati G
    J Infect Dis; 2022 Jan; 225(1):121-129. PubMed ID: 34107037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A global to local genomics analysis of Clostridioides difficile ST1/RT027 identifies cryptic transmission events in a northern Arizona healthcare network.
    Williamson CHD; Stone NE; Nunnally AE; Hornstra HM; Wagner DM; Roe CC; Vazquez AJ; Nandurkar N; Vinocur J; Terriquez J; Gillece J; Travis J; Lemmer D; Keim P; Sahl JW
    Microb Genom; 2019 Jul; 5(7):. PubMed ID: 31107202
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Ötleş E; Balczewski EA; Keidan M; Oh J; Patel A; Young VB; Rao K; Wiens J
    Infect Control Hosp Epidemiol; 2023 Nov; 44(11):1776-1781. PubMed ID: 37088695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural History of Clostridioides difficile Colonization and Infection Following New Acquisition of Carriage in Healthcare Settings: A Prospective Cohort Study.
    Curry SR; Hecker MT; O'Hagan J; Kutty PK; Alhmidi H; Ng-Wong YK; Cadnum JL; Jencson AL; Gonzalez-Orta M; Saldana C; Wilson BM; Donskey CJ
    Clin Infect Dis; 2023 Jul; 77(1):77-83. PubMed ID: 36905149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genomic survey of
    Larcombe S; Williams GC; Amy J; Lim SC; Riley TV; Muleta A; Barugahare AA; Powell DR; Johanesen PA; Cheng AC; Peleg AY; Lyras D
    Microbiol Spectr; 2023 Dec; 11(6):e0135223. PubMed ID: 37815385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole genome sequencing of toxigenic Clostridium difficile in asymptomatic carriers: insights into possible role in transmission.
    Halstead FD; Ravi A; Thomson N; Nuur M; Hughes K; Brailey M; Oppenheim BA
    J Hosp Infect; 2019 Jun; 102(2):125-134. PubMed ID: 30359648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization and genotyping of isolates from cancer patients with
    de-la-Rosa-Martinez D; Bobadilla Del Valle M; Esteban-Kenel V; Zinser Peniche P; Ponce De León Garduño A; Cornejo Juárez P; Sánchez Cruz MN; Camacho-Ortiz A; Vilar-Compte D
    J Med Microbiol; 2023 Aug; 72(8):. PubMed ID: 37624363
    [No Abstract]   [Full Text] [Related]  

  • 15. Whole-genome sequencing of clinical Clostridioides difficile isolates reveals molecular epidemiology and discrepancies with conventional laboratory diagnostic testing.
    McLean K; Balada-Llasat JM; Waalkes A; Pancholi P; Salipante SJ
    J Hosp Infect; 2021 Feb; 108():64-71. PubMed ID: 33227298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core genome multilocus sequence typing of Clostridioides difficile to investigate transmission in the hospital setting.
    Filippidis P; Senn L; Poncet F; Grandbastien B; Prod'hom G; Greub G; Guery B; Blanc DS
    Eur J Clin Microbiol Infect Dis; 2023 Dec; 42(12):1469-1476. PubMed ID: 37870711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Clostridioides difficile colonization at admission to the hospital: a multi-centre study.
    Crobach MJT; Hornung BVH; Verduin C; Vos MC; Hopman J; Kumar N; Harmanus C; Sanders I; Terveer EM; Stares MD; Lawley TD; Kuijper EJ
    Clin Microbiol Infect; 2023 Jul; 29(7):891-896. PubMed ID: 36871826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A national survey of testing and management of asymptomatic carriage of C. difficile.
    Kutty PK; Beekmann SE; Sinkowitz-Cochran RL; Dubberke ER; Kuhar DT; McDonald LC; Polgreen PM
    Infect Control Hosp Epidemiol; 2019 Jul; 40(7):801-803. PubMed ID: 31106723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.
    Curry SR; Muto CA; Schlackman JL; Pasculle AW; Shutt KA; Marsh JW; Harrison LH
    Clin Infect Dis; 2013 Oct; 57(8):1094-102. PubMed ID: 23881150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridioides difficile colonization and infection in a cohort of Australian adults with cystic fibrosis.
    Tai AS; Putsathit P; Eng L; Imwattana K; Collins DA; Mulrennan S; Riley TV
    J Hosp Infect; 2021 Jul; 113():44-51. PubMed ID: 33775742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.